Clinical Trial Update: Evaluating Dactinomycin and Vincristine in Young Patients With Cancer

View source ↗

Summary

This ClinicalTrials.gov update reports on a completed pediatric cancer trial evaluating dactinomycin and vincristine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Ewing Sarcoma
• Peripheral Primitive Neuroectodermal Tumor
• Rhabdomyosarcoma
• Soft Tissue Sarcoma
• Wilms Tumor

Drugs mentioned

• Dactinomycin (dactinomycin)
• Vincristine (vincristine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Acute Lymphoblastic Leukemia, Childhood Rhabdomyosarcoma | Status: COMPLETED